Onesource Specialty Pharma
ONESOURCE · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 24, 2025

Stock Price vs Company Growth
1d
2.1%
1w
3.8%
1m
0.4%
3m
6.9%
6m
7.7%
1y
13.6%
all
4.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,585 2.1%
1,488
1,755
Company Overview

Sales
1,543 Cr
Growth: 11.5%
Profit after Tax
-48.7 Cr
Growth: -34.1%
Mid Cap
18,170 Cr
P/S: 11.8x
Industry P/S: 2.9x
Fundamentals

Sales (Cr) ₹ 1,543
Growth 11.5%
EBITDA 22.0%
P/S 11.8x
Dividend 0.0%
P/E -372.8x
Book Value ₹ 511
PEG Ratio -32.1x
ROE -0.8%
P/B 3.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

OneSource Specialty Pharma is evolved into an integrated, multimodal specialty pharmaceutical CDMO. The company specialises in offering end-to-end solutions across biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatin capsules).Awards2024-25OneSource received the Sustainable Organisation Award 2025 at the 5th Sustainability Summit hosted by UBS Forums on June 11, 2025 in Gurgaon.Received ESG award in gold category from OHSSAI Foundation.